Table 5.
Virulence genes | Total isolates, n = 110 (%) | MDR, n = 70 (%) | Male, n = 24 (%) | Female, n = 86 (%) | *p | Hospital-acquired, n = 31 (%) | Community-acquired, n = 79 (%) | *p |
---|---|---|---|---|---|---|---|---|
fyuA | 75 (68.2) | 46 (65.7) | 14 (58.3) | 61 (70.9) | 22 (71.0) | 53 (67.1) | ||
fimH | 79 (71.8) | 51 (72.9) | 20 (83.3) | 59 (68.6) | 21 (67.7) | 58 (73.4) | ||
sfaS | 11 (10) | 6 (8.6) | 2 (8.3) | 9 (10.5) | 2 (6.5) | 9 (11.4) | ||
afa/dra | 9 (8.2) | 5 (7.1) | 0 (0.0) | 9 (10.5) | 2 (6.5) | 7 (8.9) | ||
papC | 47 (42.7) | 27 (38.6) | 12 (50.0) | 35 (40.7) | 15 (48.4) | 32 (40.5) | ||
agn43 | 60 (54.5) | 39 (55.7) | 14 (58.3) | 46 (53.5) | 16 (51.6) | 44 (55.7) | ||
yfcV | 22 (20) | 15 (21.4) | 10 (41.7) | 12 (14.0) | 0.0026 | 8 (25.8) | 14 (17.7) | |
vat | 22 (20) | 13 (18.3) | 7 (29.2) | 15 (17.4) | 6 (19.4) | 16 (20.3) | ||
hlyA | 10 (9.1) | 7 (10.0) | 4 (16.7) | 6 (7.0) | 4 (12.9) | 6 (7.6) | ||
cnf1 | 3 (2.7) | 2 (2.9) | 1 (4.2) | 2 (2.3) | 1 (3.2) | 2 (2.5) | ||
kpsMTII | 41 (37.3) | 25 (35.7) | 9 (37.5) | 32 (37.2) | 18 (58.1) | 23 (29.1) | 0.0047 | |
chuA | 54 (49.1) | 32 (45.7) | 11 (45.8) | 43 (50.0) | 16 (51.6) | 38 (48.1) |
* Only statistical significant values are shown